|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Co-Administration of FOV1101-00 (Cyclosporine 0.01% or 0.02%) and Prednisolone Acetate 0.12% (PredMild®) Compared to Prednisolone Acetate 1% Alone or Vehicle Alone in Patients With Mild Ongoing Ocular Allergic Inflammation
This is a phase 2 study that will consist of 3 visits during a 3 week period conducted at up to 5 sites. The purpose of this study is to determine how effective the combination of Pred Mild® and FOV1101-00 is compared to either Pred Forte® alone or to vehicle alone in the prevention of eye allergies. Study subjects will be randomized to one of the following:
FOV1101-00 concentration 1 and Pred Mild®
FOV1101-00 concentration 2 and Pred Mild®
Vehicle of FOV1101-00 and Pred Forte®
Vehicle of FOV1101-00 and Vehicle of FOV1101-00
100 项与 CaN x PPIB x GR 相关的临床结果
100 项与 CaN x PPIB x GR 相关的转化医学
0 项与 CaN x PPIB x GR 相关的专利(医药)